Page 73 - Tcexpression2021 - Sept to Dec 2020
P. 73

The number of research reactors producing Mo99 is on the decline, whereas the demand for the Mo99 is
        increasing. Many of these reactors are reaching their end of life, and replacement reactors are not being built.

                                 Some of the leading processors’ are listed below


                                                   Maximum
                                     Average no                  Share of                          Importance
                                                    capacity
          Processor     Country       of Mo-99     per week      annual           Type of           of Mo-99
            Name                     production    (6-day Ci    total world     Organisation 1   processing to the
                                     weeks/year                  capacity                         organisation 2
                                                    99Mo)
         ANM            Australia        43          3 500        18%          Governmental         Very High
         CNEA          Argentina         46           400          2%          Governmental           High
         Curium       Netherlands        52          5 000        32%           Commercial            High
                                                                            Semi-governmental/
         IRE            Belgium          52          3 500        22%                                 High
                                                                                commercial
                         United
         NorthStar                       52           750          5%           Commercial            High
                         States
         NTP          South Africa       44          3 000        16%        Semi-governmental      Very High
         Rosatom
                        Russian
         (RIAR and     Federation        50           890          5%        Semi-governmental        Low
         KARPOV)

        Source: https://www.oecd-ilibrary.org/sites/67dec9af-en/index.html?itemId=/content/component/67dec9af-en#wrapper

        Both the reactors and processing involve a lot of engineering automation and careful handling of the highly
        radioactive elements. According to Transparency Market Research report titled, “Technetium-99m Market”, the
        global Technetium-99m market was valued at US$ 2.7 Bn in 2019 and is projected to expand at a CAGR of 3.5%
        from 2020 to 2030. Radio-pharma players drive the growth of Technetium-99m market; clinical trials applications;
        ageing population increase; new drugs Testing; and an indication of disease mortality.

        The stoppage of reactors or processing plants can impact the Molybdenum supply. Processing facilities need to be
        located close to the reactor to avoid delay in transit. So integrated Reactor Processors are essential to a successful
        Supply chain. Global Technetium-99m market includes GE Healthcare, Curium, Lantheus Medical Imaging, Inc.,
        Mallinckrodt, Siemens Healthineers, Advanced Accelerator Applications, Bayer AG, Eckert & Ziegler, Advanced
        Cyclotron Systems, Inc., Sumitomo Heavy Industries, Ltd., Philips, and Jubilant Life Sciences Limited.

































                                                                                               Sept - Dec 2020   73
   68   69   70   71   72   73   74   75   76   77   78